ASYMCHEM LAB.(TIAN.)H YC1 Asset Resilience Ratio
ASYMCHEM LAB.(TIAN.)H YC1 asset resilience ratio. ASYMCHEM LAB.(TIAN.)H YC1 (7K90) has an Asset Resilience Ratio of 5.07% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ASYMCHEM LAB.(TIAN.)H YC1 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of ASYMCHEM LAB.(TIAN.)H YC1 (2021–2025)
Asset resilience ratio of ASYMCHEM LAB.(TIAN.)H YC1 from 2021 to 2025. This chart shows how ASYMCHEM LAB.(TIAN.)H YC1's Asset Resilience Ratio has changed over time. Read debt load of ASYMCHEM LAB.(TIAN.)H YC1 for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down ASYMCHEM LAB.(TIAN.)H YC1's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 7K90 total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €1.05 Billion | 5.07% |
| Total Liquid Assets | €1.05 Billion | 5.07% |
Asset Resilience Insights
- Limited Liquidity: ASYMCHEM LAB.(TIAN.)H YC1 maintains only 5.07% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
ASYMCHEM LAB.(TIAN.)H YC1 Industry Peers by Asset Resilience Ratio
Compare ASYMCHEM LAB.(TIAN.)H YC1's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
Biotechnology | 0.00% |
|
HLB Co. Ltd
KQ:028300 |
Biotechnology | 3.29% |
|
Tubize-Fin
BR:TUB |
Biotechnology | 2.50% |
|
Shanghai Medicilon Inc
SHG:688202 |
Biotechnology | 6.69% |
|
Blue Jet Healthcare Limited
NSE:BLUEJET |
Biotechnology | 13.81% |
|
Hangzhou Biotest Biotech Co Ltd
SHG:688767 |
Biotechnology | 0.56% |
|
Shouyao Holdings (Beijing) Co. Ltd. A
SHG:688197 |
Biotechnology | 79.76% |
|
Shenzhen Weiguang Biological Products Co Ltd
SHE:002880 |
Biotechnology | 5.52% |
ASYMCHEM LAB.(TIAN.)H YC1 Asset Resilience Ratio by Year (2021–2025)
ASYMCHEM LAB.(TIAN.)H YC1 asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for ASYMCHEM LAB.(TIAN.)H YC1.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 5.51% | €1.12 Billion ≈ $1.31 Billion |
€20.28 Billion ≈ $23.71 Billion |
-2.48pp |
| 2024-12-31 | 7.98% | €1.54 Billion ≈ $1.80 Billion |
€19.29 Billion ≈ $22.55 Billion |
-1.66pp |
| 2023-12-31 | 9.64% | €1.91 Billion ≈ $2.23 Billion |
€19.77 Billion ≈ $23.11 Billion |
-2.15pp |
| 2022-12-31 | 11.79% | €2.15 Billion ≈ $2.51 Billion |
€18.24 Billion ≈ $21.32 Billion |
+9.15pp |
| 2021-12-31 | 2.65% | €401.20 Million ≈ $469.04 Million |
€15.16 Billion ≈ $17.72 Billion |
-- |
About ASYMCHEM LAB.(TIAN.)H YC1
Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization (CDMO) solutions in Mainland China and internationally. It is involved in small molecule CDMO services for projects covering multiple major disease treatment areas, such as oncology, antiviral, anti-infective, cardiovascular, and diabetes; chemical macromolecule CDMO; biomacromolecule CDMO, incl… Read more